These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 636956)

  • 21. Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
    Swedberg JE; de Veer SJ; Harris JM
    Biol Chem; 2010 Apr; 391(4):357-74. PubMed ID: 20180638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low molecular weight organic acids as inhibitors of kinin-forming activity of a rodent tumor acid protease and human plasma kallikrein.
    Back N; Steger R; Ihm JH
    Pharmacol Res Commun; 1976 Feb; 8(1):31-42. PubMed ID: 1037454
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of commercial polyvalent proteinase inhibitors. Comparative analysis of their effect on kallikreins from different sources and trypsin].
    Iarovaia GA; Dotsenko VL; Agapova EI; Stepanian EP
    Vopr Med Khim; 1980; 26(6):832-7. PubMed ID: 6161484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen.
    Nakayasu T; Nagasawa S
    J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed.
    Girolami JP; Alhenc-Gelas F; Dos Reis ML; Bascands JL; Suc JM; Corvol P; Menard J
    Adv Exp Med Biol; 1986; 198 Pt A():137-45. PubMed ID: 3643701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The regulating interrelationship of some serine proteinases from leukocyte with the human plasma kallikrein-kinin system.
    Dotsenko VL; Neshkova EA; Yarovaya GA
    Agents Actions Suppl; 1992; 38 ( Pt 2)():144-56. PubMed ID: 1462823
    [No Abstract]   [Full Text] [Related]  

  • 27. Specificity of substrate analogue inhibitors of human urinary kallikrein.
    Okunishi H; Burton J; Spragg J
    Hypertension; 1985; 7(3 Pt 2):I72-5. PubMed ID: 3846567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and properties of two rat plasma T-kininogens.
    Okamoto H; Greenbaum LM
    Adv Exp Med Biol; 1986; 198 Pt A():69-75. PubMed ID: 3544720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit.
    Wiggins RC; Giclas PC; Henson PM
    J Exp Med; 1981 Jun; 153(6):1391-404. PubMed ID: 6910482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identity of human granulocyte kininogenase and plasminogen activator].
    Ogloblina OG; Platonova LV; Martynov VF; Leont'eva LI; Sorochinskaia EI
    Ukr Biokhim Zh (1978); 1983; 55(3):285-94. PubMed ID: 6346622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of kallikrein in human plasma.
    van der Graaf F; Koedam JA; Bouma BN
    J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides.
    Okunishi H; Spragg J; Burton J; Toda N
    Adv Exp Med Biol; 1989; 247B():23-8. PubMed ID: 2481944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein.
    Mori K; Sakamoto W; Nagasawa S
    J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anterior pituitary glandular kallikrein: trypsin activation and estrogen regulation.
    Powers CA
    Mol Cell Endocrinol; 1986 Jul; 46(2):163-74. PubMed ID: 3522314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-kininogenase activity of the rat submandibular gland is predominantly due to the kallikrein-like serine protease antigen gamma.
    Berg T; Wassdal I; Mindroiu T; Sletten K; Scicli G; Carretero OA; Scicli AG
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):19-25. PubMed ID: 1741746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Action of plant proteinase inhibitors on enzymes of the kallikrein kinin system.
    Sampaio CA; Motta G; Sampaio MU; Oliva ML; Araújo MS; Stella RC; Tanaka AS; Batista IF
    Agents Actions Suppl; 1992; 36():191-9. PubMed ID: 1609642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The major plasma kallikrein inhibitor in guinea pig plasma with contrapsin-like nature.
    Imamura T; Kambara T
    Adv Exp Med Biol; 1989; 247B():67-72. PubMed ID: 2610103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.